Incidence of WHO stage 3 and 4 conditions following initiation of Anti-Retroviral Therapy in resource limited settings

Curtis, Andrea J; Marshall, Catherine S; Spelman, Tim; Greig, Jane; Elliot, Julian H; Shanks, Leslie; Du Cros, Philipp; Casas, Esther C; Da Fonseca, Marcio Silveria; O'Brien, Daniel P

dc.contributor.author	Curtis, Andrea J
dc.contributor.author	Marshall, Catherine S
dc.contributor.author	Spelman, Tim
dc.contributor.author	Greig, Jane
dc.contributor.author	Elliot, Julian H
dc.contributor.author	Shanks, Leslie
dc.contributor.author	Du Cros, Philipp
dc.contributor.author	Casas, Esther C
dc.contributor.author	Da Fonseca, Marcio Silveria
dc.contributor.author	O'Brien, Daniel P
dc.date.accessioned	2013-04-04T20:48:27Z
dc.date.available	2013-04-04T20:48:27Z
dc.date.issued	2012-12-20
dc.identifier.citation	Incidence of WHO stage 3 and 4 conditions following initiation of anti-retroviral therapy in resource limited settings. 2012, 7 (12):e52019 PLoS ONE	en_GB
dc.identifier.issn	1932-6203
dc.identifier.pmid	23284857
dc.identifier.doi	10.1371/journal.pone.0052019
dc.identifier.uri	http://hdl.handle.net/10144/278997
dc.description.abstract	To determine the incidence of WHO clinical stage 3 and 4 conditions during early anti-retroviral therapy (ART) in resource limited settings (RLS).
dc.language.iso	en	en
dc.rights	Published by Public Library of Science, [url]http://www.plosone.org/[/url] Archived on this site by Open Access permission	en_GB
dc.title	Incidence of WHO stage 3 and 4 conditions following initiation of Anti-Retroviral Therapy in resource limited settings	en
dc.contributor.department	Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia	en_GB
dc.identifier.journal	PloS One	en_GB
refterms.dateFOA	2019-03-04T10:23:26Z
html.description.abstract	To determine the incidence of WHO clinical stage 3 and 4 conditions during early anti-retroviral therapy (ART) in resource limited settings (RLS).